
CJC-1295 with DAC is a drug-affinity-complex GHRH analogue with extended plasma half-life, used as a long-acting secretagogue reference. Supplied in kits of ten sealed vials at 99.0% verified purity with a lot-specific certificate of analysis.
CJC-1295 with DAC is a drug-affinity-complex GHRH analogue with extended plasma half-life, used as a long-acting secretagogue reference. Every PureLabs lot is produced under GMP-aligned synthesis controls, filled and sealed in a controlled environment, then assayed by an independent partner laboratory using reverse-phase HPLC with mass-spectrometric confirmation. Material is released only at or above the stated 99.0% threshold; anything below it is rejected rather than sold. The certificate of analysis carries the chromatogram and MS trace for the exact lot you receive and stays archived under reference PL-1161 for the life of the batch. Available in 1 kit configuration, each containing ten vials.
Common laboratory questions about sourcing, purity, storage and shipping of CJC-1295 with DAC.
CJC-1295 with DAC ships in 1 configuration: 5 mg/vial · 10 vials/kit. Prices start at $205 per kit.
Current stock assays at 99.0% by reverse-phase HPLC with mass-spectrometric confirmation from an independent laboratory. Lots below the threshold never reach the catalog.
Yes. A lot-specific certificate of analysis including the HPLC chromatogram and MS trace accompanies every order and remains retrievable under batch reference PL-1161.
Sealed lyophilized CJC-1295 with DAC is stable at −20 °C for at least 24 months. Once reconstituted, hold at 2–8 °C and use within about three weeks.
Orders confirmed before 15:00 UTC dispatch the same working day in insulated, tracked packaging, subject to the import rules of the destination country.
No. PureLabs supplies this material strictly as a reference compound for in-vitro and laboratory research. It is not a medicine and is not for human or veterinary consumption.